Evaluate CMPX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in CMPX? | Glauxie AI

Q: What are the risks of investing in CMPX?

Compass Therapeutics, Inc. (CMPX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Thomas J. Schuetz. Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product... Employees: 39.

Q: How much debt does CMPX have?

Review CMPX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is CMPX a good long-term investment?

Evaluate CMPX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in CMPX?

🦉

Compass Therapeutics, Inc. (CMPX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOThomas J. Schuetz

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody...

Key Executives

Name	Title
Anna Gifford	Senior Manager of Communications & Chief of Staff
Arjun Prasad	Chief Commercial Officer
Barry Shin	Chief Financial Officer
Bing Gong	Chief Scientific Officer
Cynthia A. Sirard	Chief Medical Officer
James Kranz	Vice President and Head of Chemistry Manufacturing & Controls

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

CMPX Profile Financials

Is CMPX stock safe? How much debt does CMPX have? Is CMPX a good long-term investment?